Angiotensin-Converting Enzymes Quiz
80 Questions
1 Views

Angiotensin-Converting Enzymes Quiz

Created by
@CleanlyBoston

Podcast Beta

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What happens if RAAS is blocked in a patient with severe renal impairment (S.creatinine > 3 mg/dl)?

  • It will improve renal function.
  • It will aggravate renal failure. (correct)
  • It will stabilize blood pressure.
  • It will have no effect on renal function.

    • Which of the following ACE inhibitors contains a sulfhydryl (SH) group?

  • Fosinopril
  • Lisinopril
  • Captopril (correct)
  • Benazepril

    • Which ACE inhibitor is a prodrug and requires metabolic activation?

  • Lisinopril
  • Captopril
  • Enalapril (correct)
  • Benazepril

    • What is the mechanism of action of ACE inhibitors regarding bradykinin?

    <p>They prevent the degradation of bradykinin.</p> Signup and view all the answers

    How frequently should Captopril be administered to achieve therapeutic efficacy?

    <p>Every 8 hours</p> Signup and view all the answers

    Which of the following is an effect of inhibition of the RAAS?

    <p>Decreased formation of Ang-II.</p> Signup and view all the answers

    What distinguishes Aliskiren from other RAAS inhibitors?

    <p>It inhibits renin release.</p> Signup and view all the answers

    Which ACE inhibitor does not undergo significant metabolism by the liver?

    <p>Lisinopril</p> Signup and view all the answers

    What physiological condition triggers the release of renin from the juxtaglomerular cells?

    <p>Decreased glomerular filtration rate</p> Signup and view all the answers

    Which receptor does Angiotensin II primarily act on to maintain GFR despite decreased RBF?

    <p>AT1 receptors in the efferent arterioles</p> Signup and view all the answers

    What is a consequence of Angiotensin II acting on AT1 receptors outside the kidneys?

    <p>Cell hypertrophy and apoptosis</p> Signup and view all the answers

    In the context of renal ischemia, which of the following is a potential outcome if RAAS is activated?

    <p>Acute tubular necrosis</p> Signup and view all the answers

    How does the RAAS system contribute to maintaining renal function in states of low renal blood flow?

    <p>By stimulating systemic vasoconstriction</p> Signup and view all the answers

    What changes in kidney function can lead to acute oliguria?

    <p>Decreased renal blood flow and GFR</p> Signup and view all the answers

    What role does Angiotensin II play in the kidneys during low renal perfusion states?

    <p>Stimulates secretion of aldosterone</p> Signup and view all the answers

    What effect does persistent activation of the RAAS have on renal tissues?

    <p>Induces cell hypertrophy and apoptosis</p> Signup and view all the answers

    Renin is released from the juxtaglomerular cells in response to increased renal blood flow.

    <p>False</p> Signup and view all the answers

    Angiotensin II has no effect on the efferent arterioles of the kidney.

    <p>False</p> Signup and view all the answers

    The activation of the RAAS can lead to systemic vasodilation in various tissues.

    <p>False</p> Signup and view all the answers

    Acute tubular necrosis may develop as a result of renal ischemia.

    <p>True</p> Signup and view all the answers

    Angiotensin II contributes to cellular hypertrophy and apoptosis in some tissues.

    <p>True</p> Signup and view all the answers

    The RAAS system helps to increase renal blood flow when there is a decrease in blood volume.

    <p>True</p> Signup and view all the answers

    A decrease in renal blood flow and glomerular filtration rate directly triggers the release of aldosterone.

    <p>False</p> Signup and view all the answers

    Vasoconstriction of the efferent arterioles helps maintain adequate GFR even with low renal blood flow.

    <p>True</p> Signup and view all the answers

    Inhibitors of the RAAS can potentially improve renal function in cases of severe renal impairment.

    <p>False</p> Signup and view all the answers

    Captopril is a prodrug that requires liver metabolism to become active.

    <p>False</p> Signup and view all the answers

    Bradykinin is degraded by Angiotensin-converting enzyme (ACE).

    <p>True</p> Signup and view all the answers

    All ACE inhibitors listed are classified as prodrugs.

    <p>False</p> Signup and view all the answers

    Blocking Angiotensin II formation will lead to decreased vascular constriction and reduced salt and water retention.

    <p>True</p> Signup and view all the answers

    ACE inhibitors that contain a sulfhydryl (SH) group have a higher likelihood of causing immune side effects.

    <p>True</p> Signup and view all the answers

    Angiotensin-converting enzyme inhibitors must be administered every 8 hours to achieve therapeutic efficacy.

    <p>False</p> Signup and view all the answers

    Lisinopril requires renal metabolism and is not effective in patients with kidney impairment.

    <p>False</p> Signup and view all the answers

    What initiates the release of renin from juxtaglomerular cells?

    <p>A decrease in renal blood flow (RBF) leads to renal ischemia, which triggers renin release.</p> Signup and view all the answers

    How does Angiotensin II help maintain GFR despite decreased RBF?

    <p>Angiotensin II causes vasoconstriction of the efferent arterioles, thereby maintaining adequate GFR.</p> Signup and view all the answers

    Describe the systemic effects of Angiotensin II upon activation of AT1 receptors.

    <p>Angiotensin II causes systemic vasoconstriction, cellular hypertrophy, and apoptosis in various tissues.</p> Signup and view all the answers

    What condition can result from acute oliguria induced by renal ischemia?

    <p>Acute tubular necrosis may develop as a consequence of prolonged renal ischemia and acute oliguria.</p> Signup and view all the answers

    Explain the consequence of sustained RAAS activation on renal tissues.

    <p>Persistent RAAS activation leads to cellular hypertrophy and apoptosis, contributing to renal damage.</p> Signup and view all the answers

    What is the relationship between renal blood flow and glomerular filtration rate?

    <p>A decrease in renal blood flow directly leads to a decrease in glomerular filtration rate.</p> Signup and view all the answers

    What triggers the compensatory mechanisms of the RAAS in response to decreased kidney perfusion?

    <p>Renal ischemia caused by decreased renal blood flow activates the RAAS as a compensatory response.</p> Signup and view all the answers

    Identify the negative effects of Angiotensin II on tissues outside the kidneys.

    <p>Angiotensin II can induce vascular constriction, hypertrophy, and apoptosis in non-renal tissues.</p> Signup and view all the answers

    What is the primary risk of blocking RAAS in patients with severe renal impairment (S.creatinine > 3 mg/dl)?

    <p>It can aggravate renal failure.</p> Signup and view all the answers

    How do ACE inhibitors affect bradykinin levels in the body?

    <p>ACE inhibitors prevent the degradation of bradykinin.</p> Signup and view all the answers

    Which class of drug includes β-blockers, α-methyldopa, and clonidine in relation to RAAS inhibition?

    <p>These drugs are inhibitors of renin release.</p> Signup and view all the answers

    Identify a key pharmacological property that differentiates captopril from other ACE inhibitors.

    <p>Captopril contains a sulfhydryl (SH) group.</p> Signup and view all the answers

    Which ACE inhibitors listed are classified as prodrugs?

    <p>Fosinopril and Enalapril are classified as prodrugs.</p> Signup and view all the answers

    What is the role of angiotensin II in relation to glomerular filtration rate (GFR)?

    <p>Angiotensin II helps maintain GFR despite low renal blood flow.</p> Signup and view all the answers

    Describe the impact of ACE inhibitors on aldosterone release.

    <p>ACE inhibitors inhibit aldosterone release.</p> Signup and view all the answers

    What is the significance of using an ACE inhibitor like lisinopril in patients with mild renal impairment (S.creatinine up to 3 mg/dl)?

    <p>Lisinopril can be safely used to block RAAS in mild renal impairment.</p> Signup and view all the answers

    The renin-angiotensin-aldosterone (RAAS) system is activated in response to ↓ RBF and ↓ GFR due to renal ______.

    <p>ischemia</p> Signup and view all the answers

    Renin is released from the juxtaglomerular cells as a rescue message to initiate stimulation of the ______ system.

    <p>RAAS</p> Signup and view all the answers

    Angiotensin II acts on AT1 receptors causing ______ of the efferent arterioles to maintain GFR.

    <p>vasoconstriction</p> Signup and view all the answers

    Activation of AT1 receptors outside the kidneys causes systemic ______, hypertrophy, and apoptosis.

    <p>vasoconstriction</p> Signup and view all the answers

    Chronic activation of the RAAS can lead to ______ renal tissues and may induce degenerative changes.

    <p>damaging</p> Signup and view all the answers

    Acute oliguria may develop due to renal ______ resulting from activation of the RAAS.

    <p>ischemia</p> Signup and view all the answers

    Angiotensin II plays a role in maintaining adequate GFR despite decreases in renal ______ flow.

    <p>blood</p> Signup and view all the answers

    The release of ______ is a compensatory mechanism in response to decreased renal perfusion.

    <p>renin</p> Signup and view all the answers

    Inhibition of the RAAS will correct the hypertension but also will ↓ GFR and aggravate _____ if renal ischemia was grave.

    <p>RF</p> Signup and view all the answers

    Inhibitors of plasma renin activity include _____ such as aliskiren.

    <p>drugs</p> Signup and view all the answers

    Normal S.creatinine is _____ mg/dl.

    <p>0.3-1.2</p> Signup and view all the answers

    Captopril, zofenopril, and alacepril are examples of SH-containing _____ inhibitors.

    <p>ACE</p> Signup and view all the answers

    ACE inhibitors inhibit Ang-converting enzyme (ACE) leading to the inhibition of both Ang-II formation and _____ release.

    <p>aldosterone</p> Signup and view all the answers

    If S.creatinine is up to 3 mg/dl, you can block the RAAS, but blocking the RAAS is dangerous if S.creatinine is greater than _____ mg/dl.

    <p>3</p> Signup and view all the answers

    ACE inhibitor frequency of administration varies, with Captopril being administered every _____ hours.

    <p>8</p> Signup and view all the answers

    Bradykinin is prevented from degradation primarily through the action of _____ inhibitors.

    <p>ACE</p> Signup and view all the answers

    Match the following ACE inhibitors with their pharmacological properties:

    <p>Captopril = Contains SH group and causes immune side effects Fosinopril = Prodrug with liver and kidney metabolism Lisinopril = No significant liver metabolism Enalapril = Prodrug and does not cause immune side effects</p> Signup and view all the answers

    Match the following substances with their role in the RAAS system:

    <p>Renin = Initiates RAAS activation in response to decreased RBF Angiotensin II = Promotes vasoconstriction and increases blood pressure Aldosterone = Stimulates sodium and water retention Bradykinin = Potent vasodilator degraded by ACE</p> Signup and view all the answers

    Match the following statements about RAAS inhibition with their outcomes:

    <p>Inhibition of RAAS = Corrects hypertension but may reduce GFR β-blockers = Inhibitors of renin release ACE inhibitors = Inhibit formation of Angiotensin II Aliskiren = Direct inhibitor of plasma renin activity</p> Signup and view all the answers

    Match the following drugs with their administration frequency:

    <p>Captopril = Every 8 hours Fosinopril = Every 12 hours Lisinopril = Once every 24 hours Enalapril = Every 12 hours</p> Signup and view all the answers

    Match the following ACE inhibitors with their types regarding SH group presence:

    <p>Captopril = SH-containing drug Fosinopril = Non SH-containing drug Benazepril = Non SH-containing drug Alacepril = SH-containing drug</p> Signup and view all the answers

    Match the following conditions with their implications for RAAS blocking:

    <p>S.creatinine up to 3 mg/dl = Blocking RAAS is permissible Severe renal impairment = Blocking RAAS can worsen renal failure Mild renal impairment = RAAS can be effectively blocked Renal ischemia = Inhibition may cause adverse outcomes</p> Signup and view all the answers

    Match the following mechanisms of action to their effects:

    <p>ACE Inhibition = Decreases Ang II formation and aldosterone release Bradykinin Preventing Degradation = Leads to increased vasodilation Inhibition of salt and water retention = Reduces blood pressure Vasodilation = Facilitated by increased bradykinin levels</p> Signup and view all the answers

    Match the following RAAS inhibitors with their specific types:

    <p>Captopril = SH-containing ACE inhibitor Ramipril = Non SH-containing ACE inhibitor Clonidine = α2-adrenergic agonist and RAAS inhibitor Aliskiren = Direct renin inhibitor</p> Signup and view all the answers

    Match the following components of the RAAS system with their functions:

    <p>Renin = Initiates the RAA system response Angiotensin II = Maintains GFR despite reduced RBF Aldosterone = Increases sodium reabsorption in kidneys AT1 receptors = Mediates vasoconstriction in systemic circulation</p> Signup and view all the answers

    Match the following outcomes with the corresponding triggers of the RAAS system:

    <p>Renal ischemia = Stimulates renin release from juxtaglomerular cells Decreased renal blood flow = Activates the compensatory mechanism of RAAS Acute oliguria = May lead to acute tubular necrosis Systemic vasoconstriction = Results from Angiotensin II acting on AT1 receptors</p> Signup and view all the answers

    Match the following effects of Angiotensin II with their specific vascular impacts:

    <p>Efferent arterioles constriction = Helps maintain GFR despite low RBF Cell hypertrophy = Contributes to degenerative changes in tissues Apoptosis = Results from prolonged stimulation of AT1 receptors Systemic vascular resistance = Increased by systemic effects of Angiotensin II</p> Signup and view all the answers

    Match the ACE inhibitors with their notable characteristics:

    <p>Captopril = Contains a sulfhydryl group Lisinopril = Does not require liver metabolism Enalapril = Is a prodrug activated by the liver Ramipril = Used for cardiovascular protection</p> Signup and view all the answers

    Match the following pathophysiological states with their relation to RAAS activation:

    <p>Acute tubular necrosis = Potential outcome of ischemia due to RAAS activation Increased renal perfusion = Aimed to mitigate effects of reduced blood flow Cellular hypertrophy = A long-term effect of sustained Angiotensin II exposure Systemic vasodilation = Can result from RAAS modulation in certain contexts</p> Signup and view all the answers

    Match the following statements about renal function with their implications on RAAS:

    <p>↓ RBF and ↓ GFR = Trigger for renin release Angiotensin II action = Supports renal function despite low perfusion Inhibition of RAAS = May improve renal outcomes in specific scenarios Chronic activation of RAAS = Harms renal tissue integrity over time</p> Signup and view all the answers

    Match the following concepts related to the RAAS system with their descriptions:

    <p>Juxtaglomerular cells = Location of renin secretion Angiotensin II effects = Leads to varying degrees of vasoconstriction RAAS system response = Compensatory mechanism for hemodynamic stability Renal blood flow dynamics = Essential for maintaining glomerular filtration rate</p> Signup and view all the answers

    Match the following ACE inhibitor characteristics with their implications in therapy:

    <p>Captopril = Associated with immune-mediated side effects Enalapril = Requires activation for therapeutic effect Lisinopril = Eliminated primarily by the kidneys Ramipril = Demonstrated renal and cardiovascular protective effects</p> Signup and view all the answers

    Study Notes

    Overview of RAAS and ACE Inhibitors

    • RAAS (renin-angiotensin-aldosterone system) regulates blood pressure and fluid balance.
    • Renal ischemia leads to decreased renal blood flow (RBF) and glomerular filtration rate (GFR), risking acute tubular necrosis.
    • Juxtaglomerular cells release renin to initiate RAAS as a compensatory response.
    • Angiotensin II (Ang-II) activates AT1 receptors in kidney efferent arterioles, causing vasoconstriction (VC) to support GFR despite reduced RBF.
    • Ang-II also causes systemic VC and promotes cell hypertrophy and apoptosis in other tissues, leading to degenerative changes.

    Impact of Inhibiting RAAS

    • Inhibiting RAAS corrects hypertension but may worsen renal function in severe renal ischemia.
    • Normal serum creatinine (S.creatinine) levels range from 0.3-1.2 mg/dl; levels above 3 mg/dl indicate severe renal impairment.
    • In mild renal impairment (S.creatinine up to 3 mg/dl), RAAS blockade is generally safe.
    • In severe renal impairment, RAAS inhibition is dangerous and can exacerbate renal failure (RF).

    Types of Angiotensin-Converting Enzyme Inhibitors (ACEIs)

    • SH-containing drugs: Captopril, zofenopril, alacepril.
    • Non-SH-containing drugs: Enalapril, fosinopril, lisinopril, benazepril, ramipril.

    Pharmacological Properties of Selected ACEIs

    • Captopril

      • SH group: Yes
      • Immune side effects: Yes
      • Prodrug: No
      • Metabolism: Liver, kidney
      • Onset: 1-4 hours
      • Frequency: Every 8 hours
      • Sub-lingual dose: 25 mg

    • Fosinopril

      • SH group: No
      • Immune side effects: No
      • Prodrug: Yes
      • Metabolism: Liver, kidney
      • Frequency: Every 12 hours

    • Enalapril

      • SH group: No
      • Immune side effects: No
      • Prodrug: Yes
      • Metabolism: Liver
      • Frequency: Every 12 hours

    • Lisinopril

      • SH group: No
      • Immune side effects: No
      • Prodrug: No
      • Metabolism: No hepatic metabolism, kidney excretion
      • Frequency: Once daily

    • Benazepril

      • SH group: No
      • Immune side effects: No
      • Prodrug: Yes
      • Metabolism: Liver
      • Frequency: Once daily

    Mechanism of Action of ACEIs

    • ACEIs block angiotensin-converting enzyme (ACE) in vascular endothelium.
    • Result in:
      • Reduced formation of Ang-II and aldosterone, decreasing vasoconstriction and salt & water retention.
      • Inhibition of bradykinin degradation, enhancing vasodilation effects.

    Overview of RAAS and ACE Inhibitors

    • RAAS (renin-angiotensin-aldosterone system) regulates blood pressure and fluid balance.
    • Renal ischemia leads to decreased renal blood flow (RBF) and glomerular filtration rate (GFR), risking acute tubular necrosis.
    • Juxtaglomerular cells release renin to initiate RAAS as a compensatory response.
    • Angiotensin II (Ang-II) activates AT1 receptors in kidney efferent arterioles, causing vasoconstriction (VC) to support GFR despite reduced RBF.
    • Ang-II also causes systemic VC and promotes cell hypertrophy and apoptosis in other tissues, leading to degenerative changes.

    Impact of Inhibiting RAAS

    • Inhibiting RAAS corrects hypertension but may worsen renal function in severe renal ischemia.
    • Normal serum creatinine (S.creatinine) levels range from 0.3-1.2 mg/dl; levels above 3 mg/dl indicate severe renal impairment.
    • In mild renal impairment (S.creatinine up to 3 mg/dl), RAAS blockade is generally safe.
    • In severe renal impairment, RAAS inhibition is dangerous and can exacerbate renal failure (RF).

    Types of Angiotensin-Converting Enzyme Inhibitors (ACEIs)

    • SH-containing drugs: Captopril, zofenopril, alacepril.
    • Non-SH-containing drugs: Enalapril, fosinopril, lisinopril, benazepril, ramipril.

    Pharmacological Properties of Selected ACEIs

    • Captopril

      • SH group: Yes
      • Immune side effects: Yes
      • Prodrug: No
      • Metabolism: Liver, kidney
      • Onset: 1-4 hours
      • Frequency: Every 8 hours
      • Sub-lingual dose: 25 mg

    • Fosinopril

      • SH group: No
      • Immune side effects: No
      • Prodrug: Yes
      • Metabolism: Liver, kidney
      • Frequency: Every 12 hours

    • Enalapril

      • SH group: No
      • Immune side effects: No
      • Prodrug: Yes
      • Metabolism: Liver
      • Frequency: Every 12 hours

    • Lisinopril

      • SH group: No
      • Immune side effects: No
      • Prodrug: No
      • Metabolism: No hepatic metabolism, kidney excretion
      • Frequency: Once daily

    • Benazepril

      • SH group: No
      • Immune side effects: No
      • Prodrug: Yes
      • Metabolism: Liver
      • Frequency: Once daily

    Mechanism of Action of ACEIs

    • ACEIs block angiotensin-converting enzyme (ACE) in vascular endothelium.
    • Result in:
      • Reduced formation of Ang-II and aldosterone, decreasing vasoconstriction and salt & water retention.
      • Inhibition of bradykinin degradation, enhancing vasodilation effects.

    Overview of RAAS and ACE Inhibitors

    • RAAS (renin-angiotensin-aldosterone system) regulates blood pressure and fluid balance.
    • Renal ischemia leads to decreased renal blood flow (RBF) and glomerular filtration rate (GFR), risking acute tubular necrosis.
    • Juxtaglomerular cells release renin to initiate RAAS as a compensatory response.
    • Angiotensin II (Ang-II) activates AT1 receptors in kidney efferent arterioles, causing vasoconstriction (VC) to support GFR despite reduced RBF.
    • Ang-II also causes systemic VC and promotes cell hypertrophy and apoptosis in other tissues, leading to degenerative changes.

    Impact of Inhibiting RAAS

    • Inhibiting RAAS corrects hypertension but may worsen renal function in severe renal ischemia.
    • Normal serum creatinine (S.creatinine) levels range from 0.3-1.2 mg/dl; levels above 3 mg/dl indicate severe renal impairment.
    • In mild renal impairment (S.creatinine up to 3 mg/dl), RAAS blockade is generally safe.
    • In severe renal impairment, RAAS inhibition is dangerous and can exacerbate renal failure (RF).

    Types of Angiotensin-Converting Enzyme Inhibitors (ACEIs)

    • SH-containing drugs: Captopril, zofenopril, alacepril.
    • Non-SH-containing drugs: Enalapril, fosinopril, lisinopril, benazepril, ramipril.

    Pharmacological Properties of Selected ACEIs

    • Captopril

      • SH group: Yes
      • Immune side effects: Yes
      • Prodrug: No
      • Metabolism: Liver, kidney
      • Onset: 1-4 hours
      • Frequency: Every 8 hours
      • Sub-lingual dose: 25 mg

    • Fosinopril

      • SH group: No
      • Immune side effects: No
      • Prodrug: Yes
      • Metabolism: Liver, kidney
      • Frequency: Every 12 hours

    • Enalapril

      • SH group: No
      • Immune side effects: No
      • Prodrug: Yes
      • Metabolism: Liver
      • Frequency: Every 12 hours

    • Lisinopril

      • SH group: No
      • Immune side effects: No
      • Prodrug: No
      • Metabolism: No hepatic metabolism, kidney excretion
      • Frequency: Once daily

    • Benazepril

      • SH group: No
      • Immune side effects: No
      • Prodrug: Yes
      • Metabolism: Liver
      • Frequency: Once daily

    Mechanism of Action of ACEIs

    • ACEIs block angiotensin-converting enzyme (ACE) in vascular endothelium.
    • Result in:
      • Reduced formation of Ang-II and aldosterone, decreasing vasoconstriction and salt & water retention.
      • Inhibition of bradykinin degradation, enhancing vasodilation effects.

    Overview of RAAS and ACE Inhibitors

    • RAAS (renin-angiotensin-aldosterone system) regulates blood pressure and fluid balance.
    • Renal ischemia leads to decreased renal blood flow (RBF) and glomerular filtration rate (GFR), risking acute tubular necrosis.
    • Juxtaglomerular cells release renin to initiate RAAS as a compensatory response.
    • Angiotensin II (Ang-II) activates AT1 receptors in kidney efferent arterioles, causing vasoconstriction (VC) to support GFR despite reduced RBF.
    • Ang-II also causes systemic VC and promotes cell hypertrophy and apoptosis in other tissues, leading to degenerative changes.

    Impact of Inhibiting RAAS

    • Inhibiting RAAS corrects hypertension but may worsen renal function in severe renal ischemia.
    • Normal serum creatinine (S.creatinine) levels range from 0.3-1.2 mg/dl; levels above 3 mg/dl indicate severe renal impairment.
    • In mild renal impairment (S.creatinine up to 3 mg/dl), RAAS blockade is generally safe.
    • In severe renal impairment, RAAS inhibition is dangerous and can exacerbate renal failure (RF).

    Types of Angiotensin-Converting Enzyme Inhibitors (ACEIs)

    • SH-containing drugs: Captopril, zofenopril, alacepril.
    • Non-SH-containing drugs: Enalapril, fosinopril, lisinopril, benazepril, ramipril.

    Pharmacological Properties of Selected ACEIs

    • Captopril

      • SH group: Yes
      • Immune side effects: Yes
      • Prodrug: No
      • Metabolism: Liver, kidney
      • Onset: 1-4 hours
      • Frequency: Every 8 hours
      • Sub-lingual dose: 25 mg

    • Fosinopril

      • SH group: No
      • Immune side effects: No
      • Prodrug: Yes
      • Metabolism: Liver, kidney
      • Frequency: Every 12 hours

    • Enalapril

      • SH group: No
      • Immune side effects: No
      • Prodrug: Yes
      • Metabolism: Liver
      • Frequency: Every 12 hours

    • Lisinopril

      • SH group: No
      • Immune side effects: No
      • Prodrug: No
      • Metabolism: No hepatic metabolism, kidney excretion
      • Frequency: Once daily

    • Benazepril

      • SH group: No
      • Immune side effects: No
      • Prodrug: Yes
      • Metabolism: Liver
      • Frequency: Once daily

    Mechanism of Action of ACEIs

    • ACEIs block angiotensin-converting enzyme (ACE) in vascular endothelium.
    • Result in:
      • Reduced formation of Ang-II and aldosterone, decreasing vasoconstriction and salt & water retention.
      • Inhibition of bradykinin degradation, enhancing vasodilation effects.

    Overview of RAAS and ACE Inhibitors

    • RAAS (renin-angiotensin-aldosterone system) regulates blood pressure and fluid balance.
    • Renal ischemia leads to decreased renal blood flow (RBF) and glomerular filtration rate (GFR), risking acute tubular necrosis.
    • Juxtaglomerular cells release renin to initiate RAAS as a compensatory response.
    • Angiotensin II (Ang-II) activates AT1 receptors in kidney efferent arterioles, causing vasoconstriction (VC) to support GFR despite reduced RBF.
    • Ang-II also causes systemic VC and promotes cell hypertrophy and apoptosis in other tissues, leading to degenerative changes.

    Impact of Inhibiting RAAS

    • Inhibiting RAAS corrects hypertension but may worsen renal function in severe renal ischemia.
    • Normal serum creatinine (S.creatinine) levels range from 0.3-1.2 mg/dl; levels above 3 mg/dl indicate severe renal impairment.
    • In mild renal impairment (S.creatinine up to 3 mg/dl), RAAS blockade is generally safe.
    • In severe renal impairment, RAAS inhibition is dangerous and can exacerbate renal failure (RF).

    Types of Angiotensin-Converting Enzyme Inhibitors (ACEIs)

    • SH-containing drugs: Captopril, zofenopril, alacepril.
    • Non-SH-containing drugs: Enalapril, fosinopril, lisinopril, benazepril, ramipril.

    Pharmacological Properties of Selected ACEIs

    • Captopril

      • SH group: Yes
      • Immune side effects: Yes
      • Prodrug: No
      • Metabolism: Liver, kidney
      • Onset: 1-4 hours
      • Frequency: Every 8 hours
      • Sub-lingual dose: 25 mg

    • Fosinopril

      • SH group: No
      • Immune side effects: No
      • Prodrug: Yes
      • Metabolism: Liver, kidney
      • Frequency: Every 12 hours

    • Enalapril

      • SH group: No
      • Immune side effects: No
      • Prodrug: Yes
      • Metabolism: Liver
      • Frequency: Every 12 hours

    • Lisinopril

      • SH group: No
      • Immune side effects: No
      • Prodrug: No
      • Metabolism: No hepatic metabolism, kidney excretion
      • Frequency: Once daily

    • Benazepril

      • SH group: No
      • Immune side effects: No
      • Prodrug: Yes
      • Metabolism: Liver
      • Frequency: Once daily

    Mechanism of Action of ACEIs

    • ACEIs block angiotensin-converting enzyme (ACE) in vascular endothelium.
    • Result in:
      • Reduced formation of Ang-II and aldosterone, decreasing vasoconstriction and salt & water retention.
      • Inhibition of bradykinin degradation, enhancing vasodilation effects.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    pharma fouda 2_p55-56.pdf

    Description

    Test your knowledge on Angiotensin-Converting Enzyme Inhibitors (ACEIs) and their role in the renin-angiotensin-aldosterone system (RAAS). This quiz covers key concepts related to renal function and the effects of ACE inhibitors on renal ischemia. Perfect for students in pharmacology and medicine.

    More Like This

    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser